2004

SPIRIT FIRST 30-Day and FUTURE II One-Year Results Continue to Support Benefit of Everolimus Eluting Coronary Stents Indianapolis, Ind., and Paris - Guidant Corporation (NYSE: GDT) today announced...

Evalve, Inc.''s Innovative Technology Designed to Offer New Treatment Option for Debilitating Condition Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced...

Trial Results Support Therapy for Extending and Improving the Lives of People with Advanced Heart Failure Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...

Dollens will Remain President and CEO Until His Retirement; Guido J. Neels Elevated to Chief Operating Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will announce today at its...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a second quarter dividend of $0.10 per share on outstanding common stock. This...